Innovation Spotlight: Alex Zhavoronkov from Insilico Medicine

By JLABS

In the latest edition of our Innovator Spotlight series, we spoke to Alex Zhavoronkov, Founder and CEO of Insilico Medicine, to learn more about the company, his mission and vision, as well as his entrepreneurial journey so far. As both a collaboration partner and Johnson & Johnson Innovation – JLABS resident company, we also wanted to find out more about his experience working with us.

What does Insilico Medicine do?

Insilico Medicine has a mission to accelerate drug discovery and development by continuously inventing and deploying new artificial intelligence technologies. The company aims to become a pioneer in this field by providing state-of-the-art AI solutions to top pharma and biotechnology companies to enable streamlined R&D efforts and transform the way therapeutics are discovered.

If you’re working on an early-stage healthcare innovation and looking for collaboration, incubation or investment opportunities, connect with us.

Scan the QR code below to visit our website to find out about our areas of interest and to submit your non-confidential company information for review.

barcode

https://jji.jnj/apac